Page last updated: 2024-08-26

mafosfamide and Neutropenia

mafosfamide has been researched along with Neutropenia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bonati, A; Carlo-Stella, C; Mangoni, L; Rizzoli, V	1
Futami, H; Jansen, R; Keller, J; Longo, DL; MacPhee, MJ; McCormick, K; Oppenheim, JJ; Ruscetti, FW; Wiltrout, RH	1

Reviews

1 review(s) available for mafosfamide and Neutropenia

Article	Year
Hematopoietic growth factors: in vitro and in vivo studies in bone marrow transplantation. International journal of cell cloning, 1990, Volume: 8 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Colony-Stimulating Factors; Cyclophosphamide; Hematopoiesis; Humans; In Vitro Techniques; Leukemia, Myeloid; Neutropenia; Transplantation, Autologous	1990

Other Studies

1 other study(ies) available for mafosfamide and Neutropenia

Article	Year
Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy. Journal of immunology (Baltimore, Md. : 1950), 1990, Dec-15, Volume: 145, Issue:12 Topics: Animals; Carcinoma; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluorouracil; In Vitro Techniques; Interleukin-1; Kidney Neoplasms; Leukopenia; Lung; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neutropenia; Recombinant Proteins; Survival Analysis; Tumor Cells, Cultured	1990

Article

Year

Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy.

Journal of immunology (Baltimore, Md. : 1950), 1990, Dec-15, Volume: 145, Issue:12

Topics: Animals; Carcinoma; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluorouracil; In Vitro Techniques; Interleukin-1; Kidney Neoplasms; Leukopenia; Lung; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neutropenia; Recombinant Proteins; Survival Analysis; Tumor Cells, Cultured

1990